Latest Tech Arcade stories, page 4: bite-size news on AI, startups, funding, chips, robotics and biotech, every story sourced.
ByteDance spun its in-house AI-for-science team into Anew Labs, which raised $290M at a $1.5B valuation with the TikTok owner keeping 56% — four drug programs, none yet in human trials.
Profound raised a $180M Series D at a $1.8B valuation to get brands named inside ChatGPT, Gemini and Perplexity answers — the AI-era rewrite of SEO.
AIUC raised a $40M Series A led by Ribbit Capital to certify and insure AI agents, running ~5,000 adversarial tests per audit. The barrier to enterprise AI isn't intelligence, it's liability.
Open Cosmos raised a €300M Series C — about $348M — to reach unicorn status and give Europe its own sovereign satellite infrastructure, one satellite a day.
A $115B fintech giant got breached without a line of malware: an attacker spoofed a real government email domain, and Revolut mailed back passports, selfies, IBANs, and full Bitcoin transaction histories.
Ivonescimab lived a median 30.8 months vs Keytruda's 22.6 in a head-to-head lung cancer trial — the first clear survival win over the world's best-selling drug.
Cognition's valuation leapt from $26B to $48B in four months on a $2B Series E, yet its revenue multiple stayed pinned near 53x. Here's what that flat number reveals about the AI-coding boom.
Nvidia is paying $12.93 billion for Hugging Face, the 'GitHub of AI' — its largest acquisition ever, at roughly 86 times revenue. Inside the biggest check in the company's history.
An ex-Apple car engineer's startup, Maven Robotics, exits stealth with a $100M Series A to build wheeled warehouse robots that stack boxes — no legs required.
Tencent-backed Enflame raised $911 million, then opened 188% higher on its Shanghai debut — closing near $25.5 billion despite holding just 1.7% of China's AI chip market.
Elon Musk's tunnel startup just raised $3 billion at a $23 billion valuation, led by the UAE, which is also its biggest customer. Here's why concrete is suddenly worth more than most chatbots.
Reno chip startup Positron just raised $875 million at a $5 billion valuation on a bet against high-bandwidth memory the priciest, scarcest part of an AI chip.
Harvey raised $550M at roughly a $15.5B valuation, double its March price, on $400M in revenue. Inside the 39x-multiple bet that AI eats the billable hour.
Cognition just raised $2B at a $48B valuation, doubling its price in four months as Devin's run-rate revenue nears $900M.
BrainChild Bio raised $116M to run the pivotal trial for BCB-276, a CAR-T that pushed DIPG survival from ~11 to 19.8 months in a cancer that has beaten every drug for 50 years.
Stoke Space raised a $1 billion Series E, pushing its total to $2.3 billion, for a fully reusable Nova rocket that hasn't flown yet — first launch is targeted for early 2027.
Samsung led a EUR3 billion Series D into Mistral AI, nearly doubling the French lab's valuation to about $24 billion in a year - with ASML and Nvidia along for the ride.
Pixxel just raised a $100M Series C — India's largest space-tech round ever — to scale six hyperspectral satellites reading the planet's chemistry from orbit.
Qualcomm Ventures led a $70M round in smart-ring maker Ultrahuman at a ~$365M valuation, a year after a US import ban nearly wiped it out.
An AI benchmark leapt from 2.5% to 16% of real freelance jobs in eight months. In Nairobi, that abstract number already erased 40,000 essay-writing livelihoods.
Eli Lilly is paying up to $2.88 billion for Merida Biosciences, a 16-month-old startup whose lead autoimmune drug is still in Phase 1.
Crusoe raised ~$3B at a $30B valuation, roughly tripling in 11 months, then signed a $13B AI cloud deal with trading firm Jane Street.
Revolution Medicines' RASONQUE is the first broad RAS-targeted pill for metastatic pancreatic cancer, nearly doubling median survival to 13.2 months. The catch: $39,800 a month.
Broadcom sold $16.7B of custom AI chips in one quarter, up 221%, with Google, Anthropic and OpenAI on the roster. So why did the stock fall?
